Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Samantha Y. A. Terry"'
Autor:
Jordan Cheng, Joke Zink, Edward O’Neill, Bart Cornelissen, Julie Nonnekens, Lefteris Livieratos, Samantha Y. A. Terry
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Background Peptide receptor radionuclide therapy (PRRT) uses [177Lu]Lu-[DOTA0-Tyr3]octreotate ([177Lu]Lu-DOTA-TATE) to treat patients with neuroendocrine tumours (NETs) overexpressing the somatostatin receptor 2A (SSTR2A). It has shown signi
Externí odkaz:
https://doaj.org/article/c2dfe895678c431e9e12583837aa8980
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 334 (2024)
This review article explores the evolving landscape of Molecular Radiotherapy (MRT), emphasizing Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumours (NETs). The primary focus is on the transition from β-emitting radiopharmaceutic
Externí odkaz:
https://doaj.org/article/a2dc7fdf894f4e8d85386a1d28da0922
Autor:
Erik H. J. G. Aarntzen, Edel Noriega-Álvarez, Vera Artiko, André H. Dias, Olivier Gheysens, Andor W. J. M. Glaudemans, Chiara Lauri, Giorgio Treglia, Tim van den Wyngaert, Fijs W. B. van Leeuwen, Samantha Y. A. Terry
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Inflammatory musculoskeletal diseases represent a group of chronic and disabling conditions that evolve from a complex interplay between genetic and environmental factors that cause perturbations in innate and adaptive immune responses. Unde
Externí odkaz:
https://doaj.org/article/8d66abcd47cd4ca5a35470f7dcf71d70
Autor:
Katarzyna M. Osytek, Philip J. Blower, Ines M. Costa, Gareth E. Smith, Vincenzo Abbate, Samantha Y. A. Terry
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Background Auger electron-emitting radionuclides have potential in targeted treatment of small tumors. Thallium-201 (201Tl), a gamma-emitting radionuclide used in myocardial perfusion scintigraphy, decays by electron capture, releasing aroun
Externí odkaz:
https://doaj.org/article/a54aac6021dd4c23a85faf8e89d0cb07
Autor:
Ines M. Costa, Noor Siksek, Alessia Volpe, Francis Man, Katarzyna M. Osytek, Elise Verger, Giuseppe Schettino, Gilbert O. Fruhwirth, Samantha Y. A. Terry
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 24, p 13466 (2021)
Auger electron-emitters increasingly attract attention as potential radionuclides for molecular radionuclide therapy in oncology. The radionuclide technetium-99m is widely used for imaging; however, its potential as a therapeutic radionuclide has not
Externí odkaz:
https://doaj.org/article/11d5eae5bf084bd6b24dd3daa41f5cc2
Autor:
Cinzia Imberti, Pierre Adumeau, Julia E. Blower, Fahad Al Salemee, Julia Baguña Torres, Jason S. Lewis, Brian M. Zeglis, Samantha Y. A. Terry, Philip J. Blower
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1496 (2020)
Pretargeting is widely explored in immunoPET as a strategy to reduce radiation exposure of non-target organs and allow the use of short-lived radionuclides that would not otherwise be compatible with the slow pharmacokinetic profiles of antibodies. H
Externí odkaz:
https://doaj.org/article/673bc39c55754eba9f9d9ba70b77742e
Autor:
Ozgul Ekmekcioglu, Samantha Y A Terry, Silvia Morbelli, Juliano J. Cerci, Helle D Zacho, Steffie Peters, Xavier Boulvard Chollet, Fred Verzijlbergen
Publikováno v:
Ekmekcioglu, O, Terry, S Y A, Morbelli, S, Cerci, J J, Zacho, H D, Peters, S, Chollet, X B & Verzijlbergen, F 2023, ' Superfluous, controversial and luxury issues in nuclear medicine ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 9, pp. 2582-2587 . https://doi.org/10.1007/s00259-023-06228-x
Ekmekcioglu, O, Terry, S Y A, Morbelli, S, Cerci, J J, Zacho, H D, Peters, S, Chollet, X B & Verzijlbergen, F 2023, ' Superfluous, controversial and luxury issues in nuclear medicine ', European Journal of Nuclear Medicine and Molecular Imaging . https://doi.org/10.1007/s00259-023-06228-x
European Journal of Nuclear Medicine and Molecular Imaging, 50, 9, pp. 2582-2587
Ekmekcioglu, O, Terry, S Y A, Morbelli, S, Cerci, J J, Zacho, H D, Peters, S, Chollet, X B & Verzijlbergen, F 2023, ' Superfluous, controversial and luxury issues in nuclear medicine ', European Journal of Nuclear Medicine and Molecular Imaging . https://doi.org/10.1007/s00259-023-06228-x
European Journal of Nuclear Medicine and Molecular Imaging, 50, 9, pp. 2582-2587
Many recent developments in Nuclear Medicine are being implemented in clinical practice today, but at the same time raise a lot of fundamental questions. Do we really need all these new techniques and radiopharmaceuticals, and what are their indicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393136e944fbdafb32c48979b974495a
https://vbn.aau.dk/da/publications/95e6a7b2-a042-4587-bcb4-8cf623a9cb55
https://vbn.aau.dk/da/publications/95e6a7b2-a042-4587-bcb4-8cf623a9cb55
Autor:
Ingebjørg N, Hungnes, Fahad, Al-Salemee, Peter J, Gawne, Thomas, Eykyn, R Andrew, Atkinson, Samantha Y A, Terry, Fiona, Clarke, Philip J, Blower, Paul G, Pringle, Michelle T, Ma
Publikováno v:
Dalton Transactions (Cambridge, England : 2003)
Radiotracers labelled with technetium-99m (99mTc) enable accessible diagnostic imaging of disease, provided that radiotracer preparation is simple. Whilst 99mTc radiopharmaceuticals for imaging perfusion are routinely prepared from kits, and regularl
Autor:
Cinzia, Imberti, Pierre, Adumeau, Julia E, Blower, Fahad, Al Salemee, Julia, Baguña Torres, Jason S, Lewis, Brian M, Zeglis, Samantha Y A, Terry, Philip J, Blower
Publikováno v:
International Journal of Molecular Sciences
Pretargeting is widely explored in immunoPET as a strategy to reduce radiation exposure of non-target organs and allow the use of short-lived radionuclides that would not otherwise be compatible with the slow pharmacokinetic profiles of antibodies. H
Autor:
Daphne, Lobeek, Frédérique C M, Bouwman, Erik H J G, Aarntzen, Janneke D M, Molkenboer-Kuenen, Uta E, Flucke, Ha-Long, Nguyen, Miikka, Vikkula, Laurence M, Boon, Willemijn, Klein, Peter, Laverman, Wim J G, Oyen, Otto C, Boerman, Samantha Y A, Terry, Leo J, Schultze Kool, Mark, Rijpkema
Publikováno v:
J Nucl Med
Arteriovenous malformations (AVMs) have an inherent capacity to form new blood vessels, resulting in excessive lesion growth, and this process is further triggered by the release of angiogenic factors. (68)Ga-labeled arginine-glycine-aspartate tripep